Botulinum toxin B as an effective and safe treatment for neuroleptic-induced sialorrhea.

Author: HagenahJohann, KleinChristine, LencerRebekka, MoserAndreas, SteinlechnerSusanne

Paper Details 
Original Abstract of the Article :
Severe sialorrhea is a common, potentially stigmatizing and disabling side-effect of neuroleptic drugs such as clozapine. Sialorrhea also occurs in neurological disorders such as Parkinson's disease (PD). For neurological diseases, several studies have demonstrated botulinum toxin type B to be a saf...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://doi.org/10.1007/s00213-009-1689-y

データ提供:米国国立医学図書館(NLM)

Botulinum Toxin B: A Potential Oasis in the Desert of Neuroleptic-Induced Sialorrhea

Sialorrhea, or excessive drooling, can be a distressing side effect of neuroleptic medications, creating a desert of discomfort for patients. This research investigates the efficacy and safety of botulinum toxin type B as a treatment for neuroleptic-induced sialorrhea. The researchers reviewed existing studies and concluded that botulinum toxin type B is a safe and effective treatment for this condition. The authors highlight the potential for botulinum toxin type B to provide relief from the bothersome symptoms of sialorrhea.

Botulinum Toxin B: A Potential Oasis in the Desert of Neuroleptic-Induced Sialorrhea

This research suggests that botulinum toxin type B can be a valuable treatment option for patients experiencing neuroleptic-induced sialorrhea. The findings highlight its efficacy in reducing drooling and improving quality of life for those affected. The study underscores the importance of considering alternative treatment options for managing the side effects of medications.

Botulinum Toxin B: A Potential Oasis in the Desert of Neuroleptic-Induced Sialorrhea

This research offers a glimmer of hope for patients struggling with neuroleptic-induced sialorrhea. Botulinum toxin type B presents a potential oasis in the desert of treatment options, offering a way to manage the distressing symptoms of excessive drooling. The study underscores the importance of exploring innovative treatment approaches for addressing the side effects of medications and improving the lives of patients.

Dr.Camel's Conclusion

This research explores the potential of botulinum toxin type B as a treatment for neuroleptic-induced sialorrhea, a condition that can leave patients feeling isolated and uncomfortable. The study's findings suggest that botulinum toxin type B can be a safe and effective treatment option, offering a potential oasis in the desert of treatment options for this challenging condition. It highlights the importance of exploring innovative approaches to manage the side effects of medications and improve the overall well-being of patients.

Date :
  1. Date Completed 2010-03-18
  2. Date Revised 2021-10-20
Further Info :

Pubmed ID

19823807

DOI: Digital Object Identifier

10.1007/s00213-009-1689-y

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.